ADH5 and cystic fibrosis: While it is well‐known that trials using the oral GSNOR inhibitor, cavosonstat, were not effective in the treatment of cystic fibrosis (CF), it is difficult to draw any conclusions from these trials as to how these drugs will perform in asthma.